Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience - Brown, Gabrielle; Wang, Eva; Leon, Argentina; Huynh, Monica; Wehner, Mackenzie; Matro, Rebecca; Linos, Eleni; Liao, Wilson; Haemel, Anna (Journal of the American Academy of Dermatology, 2017)
Keywords: adalimumab; Adolescent; Adult; adverse event; Aged; Aged, 80 and over; certolizumab; Child; Dermatology; Drug Eruptions - diagnosis; Drug Eruptions - etiology; Drug Eruptions - therapy; etanercept; Female; golimumab; Humans; infliximab; Male; medication side effect; Middle Aged; psoriasis; Psoriasis - chemically induced; Psoriasis - diagnosis; Psoriasis - therapy; Tumor Necrosis Factor-alpha - antagonists & inhibitors; tumor necrosis factor-α inhibitor; tumor necrosis factor-α-induced psoriasis; Young Adult; medication side effect; CD; IL; etanercept; infliximab; AZA; adverse event; certolizumab; MeSH; tumor necrosis factor-α inhibitor; adalimumab; golimumab; UC; RA; IFN-α; MTX; AS; IL-23R; TH; TNF-α; tumor necrosis factor-α-induced psoriasis; psoriasis; ankylosing spondylitis; methotrexate; interleukin-23 receptor; interferon α; ulcerative colitis; interleukin; T helper; azathioprine; rheumatoid arthritis; medical subject headings; Crohn disease; tumor necrosis factor-α; T H